Quoin Pharmaceuticals Stock (NASDAQ:QNRX)
Previous Close
$7.28
52W Range
$5.01 - $54.95
50D Avg
$8.16
200D Avg
$12.40
Market Cap
$4.24M
Avg Vol (3M)
$8.13K
Beta
1.82
Div Yield
-
QNRX Company Profile
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.